Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JR-446 in Mucopolysaccharidosis Type IIIB
NCT06488924Phase 2Active, not recruiting
- Sponsor
- JCR Pharmaceuticals
- Start
- Nov 2024
- Primary completion
- Apr 2030
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of JR-446 in mucopolysaccharidosis type IIIB, sponsored by JCR Pharmaceuticals. Started Nov 2024; status: active, not recruiting.
02
Drugs
JR-446
03
Conditions
mucopolysaccharidosis type IIIB
Beyond the preview
Go deeper on NCT06488924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06488924.